Portola Pharmaceuticals beats by $0.02, misses on revenue

|About: Portola Pharmaceuticals (PTLA)|By:, SA News Editor

Portola Pharmaceuticals (NASDAQ:PTLA): Q2 EPS of -$0.76 beats by $0.02.

Revenue of $2.42M (-6.9% Y/Y) misses by $0.02M.